Koshinski Asset Management
WST icon

Koshinski Asset Management’s West Pharmaceutical WST Stock Holding History

Koshinski Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-727
Closed -$200K – 763
2025
Q4 		$200K Sell
727
-41
-5% -$11.2K 0.01% 701
2025
Q3 		$201K Buy
+768
New +$187K 0.01% 693
2022
Q2 		– Sell
-173
Closed -$71.1K – 1972
2022
Q1 		$71.1K Sell
173
-2,037
-92% -$797K 0.01% 967
2021
Q4 		$1.04M Sell
2,210
-228
-9% -$98.1K 0.08% 251
2021
Q3 		$1.04M Buy
+2,438
New +$1.03M 0.09% 247
2021
Q2 		– Sell
-2,388
Closed -$673K – 633
2021
Q1 		$673K Buy
+2,388
New +$683K 0.07% 304

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Koshinski Asset Management's WST Position: Q1 2026 in Review

Koshinski Asset Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 727 shares — an estimated $200K sold.

Koshinski Asset Management first reported a position in WST in Q1 2021 and held it in 6 quarters. The position peaked at $1.04M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Koshinski Asset Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Koshinski Asset Management sold 727 West Pharmaceutical shares in Q1 2026, an estimated $200K.
  • Koshinski Asset Management first reported a position in West Pharmaceutical in Q1 2021 and held it in 6 quarters.
  • Koshinski Asset Management's West Pharmaceutical position peaked at $1.04M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Koshinski Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.